Company Presentation • 06 Nov 2025 21:00
Company Presentation • 06 Aug 2025 20:00
Company Presentation • 16 Dec 2024 21:30
Company Presentation • 26 Jun 2025 20:30
Company Presentation • 07 May 2025 20:00
Search or
𝛼SK
𝛼SKENTITY
BeiGene (6160 HK)
BeiGene (6160 HK)
438
Analysis
Health Care • China
BeiGene, Ltd. operates as a commercial stage biopharmaceutical company. The Company focuses on discovery, development, and commercialization of molecularly targeted and immuno-oncology drugs for the treatment of cancer. BeiGene serves patients worldwide.
morex